Search - tctmd.com

Displaying 101 - 120 of 193

Sort: Relevancy | Date

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

June 13, 2019

Enlarged Left Atria Can ID Patients With ESUS Who May Benefit From a DOAC

News Daily News

Enlarged Left Atria Can ID Patients With ESUS Who May Benefit From a DOAC

April 08, 2019

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

News Daily News

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

April 04, 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

News Conference News ISC 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

February 14, 2019

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

News Daily News

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

February 08, 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

News Conference News ISC 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

February 08, 2019

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

News Conference News ISC 2019

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

February 07, 2019

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

News Daily News

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

October 26, 2018

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

August 15, 2018

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

August 13, 2018

US Preventive Services Task Force: Insufficient Evidence to Recommend ECG Screening for A-fib Detection

News Daily News

US Preventive Services Task Force: Insufficient Evidence to Recommend ECG Screening for A-fib Detection

August 07, 2018

New Review Probes Possibility of CVD Prevention Without Aspirin

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

May 23, 2018

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

May 16, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.